AGT and cardiac hypertrophy: In conclusion, we demonstrate that EGFR play a key role in cardiac hypertrophy and EGFR inhibition by either small‐molecule inhibitors or genetic silencing can protect against Ang II‐induced cardiac hypertrophy.